Reprocessing Key to MRS Proposal Faces Mixed Reaction
The public response to the DoE list of 12 sites for a second high level nuclear waste facility prompted varied views. Ben Rusche, who led the site search, faced both support and criticism, while South Carolinians welcomed the omission of their state and lawmakers weighed the need for reprocessing to recover energy and reduce toxicity.
MENTIONED IN THIS ARTICLE
Department of Energy
South Carolina
U. S
Strom Thurmond
Butler Derrick
Rusche
Savannah River
Barnwell
Mr. Rusche
Sirhan Sirhan Deserved A Lifetime Behind Bars
The essay argues Sirhan Sirhan, condemned for killing Senator Robert F. Kennedy in 1968, should remain imprisoned for life. It notes California’s capital punishment ruling, multiple parole denials, and a March parole review triggered by a state Supreme Court ruling requiring explained delays.
MENTIONED IN THIS ARTICLE
Sirhan Sirhan
Robert F. Kennedy
Los Angeles
California Supreme Court
State Board of Prison Terms
Sirhan
Soledad
State Supreme Court
Parole Board
Sen. Kennedy
White House
Gershwin impressions and anecdotes from a cub reporter
Ashley recalls interviewing George Gershwin at Folly Beach and notes he was not extremely conceited but self confident. The piece cites anecdotes from Clifton Fadiman and Oscar Levant about Gershwin’s wit genius self view and muses on how his legacy might have grown had he lived past 39.
MENTIONED IN THIS ARTICLE
George Gershwin
Folly Beach
Gershwin
Clifton Fadiman
Oscar Levant
Fadiman
George
Levant
Rossini
Liszt
Meyerbeer
Textile import bill misleads public says columnist
A columnist condemns advocates of a textile import measure as misleading. He cites statements by Northern Textile Association president Karl Spilhaus and industry claims, arguing data conflict and urging free competition and sound economic policy. The piece contrasts studies, noting varying conclusions on job losses, prices, and consumer impact.
MENTIONED IN THIS ARTICLE
Congress
Northern Textile Association
NTA
Karl Spilhaus
Spilhaus
Marketing Research Corp. of America
Data Resources Inc
Spil
Bill Lorsby
Mrca Information Services
International Business and Economics Research Corp
Indus
The Dying Can't Wait for New Cancer Therapies
The piece argues for quicker access to experimental treatments like interleukin-2 for terminally ill patients. It cites patient demand, the slow pace of FDA approval, and calls for physician supervised use and streamlined access while noting costs and controversies.
MENTIONED IN THIS ARTICLE
National Cancer Institute
NCI
The
Wall Street Journal
Also Mentioned on This Page
Ashley
Billy Graham
Gramm
Rudman OR Hollings
By Stephen Chapman
Haus
Christopher Caton
Data Resources
Burlington Industries
U.S
Chicago Tribune
DR. Graham
T.F.R
Satan
God
FDA
Biotherapeutics
Franklin, Tenn
Los Angeles Times Syndicate
Haiti